• Explore /
  • Poster
  • / Association between severe adverse event management and overall survival in patients treated with immune checkpoint inhibitor with advanced non–small-cell lung cancer.

Association between severe adverse event management and overall survival in patients treated with immune checkpoint inhibitor with advanced non–small-cell lung cancer.

Abstract Poster

Authors

Jarushka Naidoo

Jarushka Naidoo

Beaumont RCSI Cancer Center, Dublin, Ireland

Jarushka Naidoo , Douglas Buckner Johnson , Charlotte Doran , Yuexi Wang , Yan Zhang , Trong Kim Le , Sari Hopson , Brian Dreyfus , Lincy S. Lal , Charmy Vyas , Shay Goldstein , Zara Izadi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Health Services Research and Quality Improvement

Track

Quality Care/Health Services Research

Sub Track

Real-World Data/Outcomes

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 6604)

DOI

10.1200/JCO.2023.41.16_suppl.6604

Abstract #

6604

Poster Bd #

96

Abstract Disclosures

Similar Posters

First Author: Lorenzo Pilla

First Author: Thierry Landre

First Author: Talal El Zarif

First Author: Olisaemeka Ogbue